Susan Shiff
Director/Board Member at CARA THERAPEUTICS, INC.
Net worth: 131 153 $ as of 31/05/2024
Susan Shiff active positions
| Companies | Position | Start | End |
|---|---|---|---|
| CARA THERAPEUTICS, INC. | Director/Board Member | 26/06/2020 | - |
| Independent Dir/Board Member | 26/06/2020 | - | |
Synthace Ltd.
 Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Director/Board Member | 05/06/2018 | - |
Merck Global Health Innovation Fund LLC
 Merck Global Health Innovation Fund LLC Investment ManagersFinance Merck Global Health Innovation Fund LLC invests in companies located across the globe primarily in North America and Europe. The fund focuses on companies operating in the fields of digital health, drug discovery & clinical development, manufacturing, supply chain & it services. It provides financing for early and growth stage capital requirements with an investment size of USD 5 - 10 million. | Director/Board Member | - | - |
| New Jersey Symphony Orchestra | Director/Board Member | - | - |
Career history of Susan Shiff
Former positions of Susan Shiff
| Companies | Position | Start | End |
|---|---|---|---|
| Ontada | President | 01/03/2021 | 01/07/2023 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2014 | 01/03/2021 |
| Teva Pharmaceutics | Corporate Officer/Principal | - | - |
| PFIZER, INC. | Corporate Officer/Principal | - | - |
Training of Susan Shiff
| University of California, Los Angeles | Doctorate Degree |
| Cornell University | Masters Business Admin |
Statistics
International
| United States | 9 |
| 2 | |
| United Kingdom | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| CARA THERAPEUTICS, INC. | Health Technology |
| Private companies | 5 |
|---|---|
| New Jersey Symphony Orchestra | |
| Teva Pharmaceutics | |
Merck Global Health Innovation Fund LLC
Merck Global Health Innovation Fund LLC Investment ManagersFinance Merck Global Health Innovation Fund LLC invests in companies located across the globe primarily in North America and Europe. The fund focuses on companies operating in the fields of digital health, drug discovery & clinical development, manufacturing, supply chain & it services. It provides financing for early and growth stage capital requirements with an investment size of USD 5 - 10 million. | Finance |
Synthace Ltd.
Synthace Ltd. Packaged SoftwareTechnology Services Synthace Ltd. produces bio-based chemical and biological products through synthetic biology. It is a synthetic biology company with a platform of technologies for the rapid engineering and optimization of novel biological production systems. The bioengineering platform is broadly applicable across multiple industry sectors, including the production of specialty chemicals from renewable feed stocks using efficient and sustainable processes. The company was founded by Sean Ward and Markus Christian Gershater in January 2011 and is headquartered in, London, the United Kingdom. | Technology Services |
| Ontada |
- Stock Market
- Insiders
- Susan Shiff
- Experience
